Literature DB >> 2565084

X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis.

J M Puck1, R L Nussbaum, D L Smead, M E Conley.   

Abstract

X-linked severe combined immunodeficiency (SCID) (McKusick 30040; IMD4) is a disease of unknown pathogenesis characterized by severe and persistent infections from early in life that are due to absence of both cellular and humoral immune function. Although the disease has been provisionally mapped to proximal Xq, high lethality and lack of a carrier test have limited the number of scorable meioses. We performed linkage analysis in six new kindreds with X-linked SCID, using a random pattern of T-cell X inactivation to rule out the carrier state in at-risk women. Our linkage results, combined with analysis of Xq interstitial deletions, confirmed the regional assignment of X-linked SCID, narrowed the boundaries within which this locus lies to Xq13.1-q21.1, and established the locus order DXS159-(PGK1, SCID)-DXS72-DXS3, defining flanking markers for prenatal diagnosis and carrier testing.

Entities:  

Mesh:

Year:  1989        PMID: 2565084      PMCID: PMC1715634     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13.

Authors:  G de Saint Basile; B Arveiler; I Oberlé; S Malcolm; R J Levinsky; Y L Lau; M Hofker; M Debre; A Fischer; C Griscelli
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.

Authors:  J M Puck; R L Nussbaum; M E Conley
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  Clonal analysis using recombinant DNA probes from the X-chromosome.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; A C Preisinger; H F Willard; A M Michelson; A D Riggs; S H Orkin
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

5.  Genetic mapping of nine DNA markers in the q11----q22 region of the human X chromosome.

Authors:  B Arveiler; I Oberlé; J L Mandel
Journal:  Genomics       Date:  1987-09       Impact factor: 5.736

Review 6.  X-linked genetic homologies between mouse and man.

Authors:  M T Davisson
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

7.  Isolation of anonymous DNA sequences from within a submicroscopic X chromosomal deletion in a patient with choroideremia, deafness, and mental retardation.

Authors:  R L Nussbaum; J G Lesko; R A Lewis; S A Ledbetter; D H Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Multipoint linkage analysis of loci in the proximal long arm of the human X chromosome: application to mapping the choroideremia locus.

Authors:  J G Lesko; R A Lewis; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1987-04       Impact factor: 11.025

Review 9.  Diagnosis and classification of severe combined immunodeficiency disease.

Authors:  E W Gelfand; H M Dosch
Journal:  Birth Defects Orig Artic Ser       Date:  1983

10.  Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency.

Authors:  M H Nahm; J W Paslay; J M Davie
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  18 in total

1.  Isolation of DNTR polymorphisms from yeast artificial chromosomes encompassing X chromosomal loci PGK1 and DXS56.

Authors:  M B Graeber; A P Monaco; J Chelly; U Müller
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

Review 2.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

3.  An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry.

Authors:  R E Schnur; B J Trask; G van den Engh; H H Punnett; M Kistenmacher; M A Tomeo; R E Naids; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

4.  T cell immunodeficiency in dyskeratosis congenita.

Authors:  B W Lee; H K Yap; T C Quah; A Chong; C C Seah
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 5.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

6.  Physical mapping in the region of human Xq12-21.1 using pulsed field gel electrophoresis.

Authors:  A M Jones; S Malcolm; R J Levinsky; C Kinnon
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

7.  Refinement of linkage of human severe combined immunodeficiency (SCIDX1) to polymorphic markers in Xq13.

Authors:  J M Puck; M E Conley; L C Bailey
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

8.  Recombination of 4p16 DNA markers in an unusual family with Huntington disease.

Authors:  C Pritchard; N Zhu; J Zuo; L Bull; M A Pericak-Vance; J M Vance; A D Roses; A Milatovich; U Francke; D R Cox
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

Review 9.  The molecular basis of X-linked immunodeficiency disease.

Authors:  C Kinnon; R Levinsky
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

10.  X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings.

Authors:  M E Conley; R H Buckley; R Hong; C Guerra-Hanson; C M Roifman; J A Brochstein; S Pahwa; J M Puck
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.